华恒生物 (688639.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(华恒生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 1,539,034,126.351,016,220,737.71500,781,373.591,938,268,117.781,364,161,262.06849,888,607.49400,254,753.80
 营业收入(元) 1,539,034,126.351,016,220,737.71500,781,373.591,938,268,117.781,364,161,262.06849,888,607.49400,254,753.80
二、营业总成本(元) 1,382,619,720.33870,509,300.90411,603,470.891,447,706,028.021,006,806,422.12629,211,415.36310,953,639.35
 营业成本(元) 1,106,078,300.23695,125,414.56332,636,926.091,152,955,895.32800,855,787.02494,095,547.51244,814,225.07
 研发费用(元) 90,514,239.0663,352,200.8428,484,280.20108,824,394.4877,313,400.2354,351,137.6624,726,169.10
 营业税金及附加(元) 9,490,869.045,854,869.362,655,950.8410,744,013.648,190,489.385,466,558.403,004,350.78
 销售费用(元) 46,968,066.1031,571,070.7110,871,898.7850,403,621.5935,199,555.7223,913,398.737,697,747.71
 管理费用(元) 110,141,858.9166,905,121.4332,352,137.08121,681,216.6488,695,784.3256,594,790.4927,297,615.30
 财务费用(元) 19,426,386.997,700,624.004,602,277.903,096,886.35-3,448,594.55-5,210,017.433,413,531.39
  其中:利息费用(元) 27,120,928.3116,590,223.237,443,732.5910,638,219.345,408,771.082,134,207.11889,725.79
  其中:利息收入(元) 2,735,635.592,080,128.52665,131.473,048,017.252,479,420.281,676,414.94552,206.92
三、其他经营收益
 加:公允价值变动收益(元) ----313,237.93-309,539.30-276,251.63228,490.10
 加:投资收益(元) 1,043,111.40-51,080.29-2,860,577.782,777,895.532,593,081.771,353,895.07
  其中:对联营企业和合营企业的投资收益(元) 1,043,111.40-51,080.29-----
 资产处置收益(元) -71,933.90-66,998.76-28,746.05-5,224.18-17,996.20--524,294.01
 资产减值损失(元) -183,649.98-183,649.98--2,942,242.87---
 信用减值损失(元) 472,163.36521,596.531,205,714.07-403,445.47-1,001,266.26-2,039,307.74-942,976.05
 其他收益(元) 24,805,207.3517,482,098.665,878,493.7921,144,743.289,928,167.015,709,487.892,582,371.78
四、营业利润(元) 182,479,304.25163,413,402.9796,233,364.51510,903,260.37368,732,100.72226,664,202.4291,998,601.34
 加:营业外收入(元) 2,361,878.041,209,998.98358,340.421,591,649.341,390,817.07580,711.2718,160.19
 减:营业外支出(元) 730,426.76129,754.155,771.016,223,967.517,442,181.096,097,797.22267,230.64
五、利润总额(元) 184,110,755.53164,493,647.8096,585,933.92506,270,942.20362,680,736.70221,147,116.4791,749,530.89
 减:所得税费用(元) 16,114,036.8316,501,535.8310,717,330.2759,671,136.0243,281,601.2730,028,418.7610,561,193.76
六、净利润(元) 167,996,718.70147,992,111.9785,868,603.65446,599,806.18319,399,135.43191,118,697.7181,188,337.13
(一)按经营持续性分类
  持续经营净利润(元) 167,996,718.70147,992,111.9785,868,603.65446,599,806.18319,399,135.43191,118,697.7181,188,337.13
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 169,893,703.83149,707,731.8486,574,111.12449,061,466.72319,949,196.04191,236,644.4381,198,285.24
  少数股东损益(元) -1,896,985.13-1,715,619.87-705,507.47-2,461,660.54-550,060.61-117,946.72-9,948.11
 扣除非经常性损益后的净利润(元) 165,632,315.15147,503,721.0085,910,725.23438,093,424.06314,974,051.52189,454,160.7478,316,720.65
七、每股收益
 一、基本每股收益(元) 0.740.950.552.842.031.220.75
 二、稀释每股收益(元) 0.740.950.552.842.031.220.75
八、其他综合收益(元) -196,251.6588,915.7423,061.8281,725.54---
 归属于母公司股东的其他综合收益(元) -196,251.6588,915.7423,061.8281,725.54---
九、综合收益总额(元) 167,800,467.05148,081,027.7185,891,665.47446,681,531.72319,399,135.43191,118,697.7181,188,337.13
 归属于母公司所有者的综合收益总额(元) 169,697,452.18149,796,647.5886,597,172.94449,143,192.26319,949,196.04191,236,644.4381,198,285.24
 归属于少数股东的综合收益总额(元) -1,896,985.13-1,715,619.87-705,507.47-2,461,660.54-550,060.61-117,946.72-9,948.11
公告日期 2024-10-292024-08-282024-04-222024-04-222023-10-262023-08-292023-04-26
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院